Physician in the Loop

One in six health systems with top AI returns reports AI-related layoffs

The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.

Read the post and its sources

Get the free email briefing

One in six of the U.S. hospitals and health systems earning the most from artificial intelligence reported AI-related layoffs, according to a Vizient survey of 416 senior leaders released Nov. 12.

The survey put the average return on AI deployments at 3.2 times their cost, a self-reported estimate, with the largest returns in pharmacy, supply chain and utilization management. State medical boards, meanwhile, plan to publish draft guidance in December on physician accountability when AI performs clinical work, the Federation of State Medical Boards and the American Medical Association said.

Two more measles deaths, in Pennsylvania and Wisconsin, brought this year's U.S. toll to 10, a day after the country lost its measles elimination status, and Congo's Ebola outbreak passed 11,000 cases.

In this episode

• One in six health systems with the highest AI returns reported AI-related layoffs, a Vizient survey of 416 leaders finds
• State medical boards will publish draft rules in December on who answers when AI does a physician's work
• Measles deaths reach 10 this year as Pennsylvania and Wisconsin report two more, while the CDC lists six
• Congo's Ebola outbreak passes 11,000 cases and 5,387 deaths, and the strain behind it has no known vaccine
• AI reading of a routine ECG predicted dilated cardiomyopathy about as well as echocardiography across four cohorts
• DEA places the narcolepsy drug oveporexton in Schedule IV, effective immediately
• Lower-dose CagriSema cut body weight 21% versus 2% on placebo at 68 weeks in a 309-patient trial

U.S. loses measles elimination status after 26 years, reports say

The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.

Read the post and its sources

Get the free email briefing

The United States has lost the measles elimination status it held since 2000, a Pan American Health Organization commission found, The Wall Street Journal, Reuters and CNN reported Friday.

The commission met Nov. 10 to 13, and the CDC lists 5,182 confirmed U.S. cases this year as of Nov. 5. Separately, CMS told states they may hold off on denying or ending Medicaid coverage under the new work requirement until June 30, 2027, though the rules still start Jan. 1, and Houston Methodist's innovation chief said AI vendors must show staff reductions, not just time saved, before the system buys.

In this episode

• The U.S. no longer counts as measles-free after 26 years, a regional commission found, news outlets report
• Medicaid work rules still start Jan. 1, but states may hold off coverage losses until June 30, 2027
• Houston Methodist wants AI vendors to show staff reductions, not just hours saved, before it buys
• Synchron pauses trials of its wireless brain implant and cuts jobs, saying the pause is not safety related
• Smartphone coaching from pregnancy to a year postpartum fails to lower BMI in 865 women at risk of gestational diabetes
• One in 10 patients given andexanet for factor Xa inhibitor bleeding had a clot, and restarting anticoagulation lowered the risk
• Community health workers who prescribed blood pressure pills with decision support matched nurse-led care in a 103-village trial
• FDA approves obinutuzumab as the first drug for primary membranous nephropathy after 36% reached remission versus 6% on tacrolimus

Federal regulators have barred two of the 17 surprise-billing arbitrators from new disputes, citing their performance. Which standards they missed, and what becomes of their open cases, the agencies have not yet said.

Read the special topic and its sources: https://physicianintheloop.org/specials/surprise-billing-arbitrators/

The voice on this episode is generated by AI. It reads a special topic from Physician in the Loop as written; every fact in it links to its source.

Patients will accept medical AI on one condition: that a doctor can overrule it. That veto is being sold and stretched faster than anyone is paying to keep it real.

Read the letter and its sources: https://physicianintheloop.org/letters/2026-11-09/

The voice on this episode is generated by AI. It reads the week's Friday letter at Physician in the Loop as written; every fact in the letter links to its source.

American Cancer Society now urges PSA tests every 2 years from age 50

The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.

Read the post and its sources

Get the free email briefing

The American Cancer Society on Thursday dropped its 16-year-old shared-decision stance on prostate cancer screening and now recommends a PSA test every two years for average-risk men 50 to 69, the society said.

Black men and men with a strong family history are to be screened every year from 45, and the guideline sets PSA thresholds, a repeat test and MRI or a biomarker before biopsy. Separately, a Doximity survey of 3,379 physicians found that 52% use AI for work every day and about three in four caught it in a factual error in the past year, and a BPROAD trial analysis in The BMJ found that a systolic target under 120 mm Hg did not reduce dementia or mild cognitive impairment in type 2 diabetes.

In this episode

• American Cancer Society now recommends PSA screening every 2 years from 50 to 69, ending its 2010 shared-decision stance
• Half of U.S. physicians now use AI every day, and three in four caught it in a factual error this year, Doximity survey finds
• A systolic target under 120 did not lower dementia or mild cognitive impairment in 12,434 adults with type 2 diabetes
• FDA clears AI that flags brain aneurysms larger than 3 mm on head CT angiography and tracks their growth between scans
• MDCalc launches CrossCover, which strips patient identifiers from clinicians' questions to medical AI chatbots

AI health products tend to report how many people they reached and how quickly. The test that matters is whether those patients did better, and buyers should ask before they scale.

Read the special topic and its sources: https://physicianintheloop.org/specials/better-not-sooner/

The voice on this episode is generated by AI. It reads a special topic from Physician in the Loop as written; every fact in it links to its source.

AMA says AI cannot be licensed as a doctor and vendors should own its errors

The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.

Read the post and its sources

Get the free email briefing

The American Medical Association's House of Delegates voted Nov. 9 that artificial intelligence cannot hold a medical license or a physician's title, and that vendors should be liable when a defective tool harms a patient.

The policy, released Nov. 10, says AI belongs in physician-led teams and seeks liability protection for physicians who decline an AI recommendation. A West Health-Gallup survey found 56% of patients comfortable with AI diagnosis that a clinician can override, against the 36% that primary care physicians predicted.

Oura agreed to buy AI primary care company Counsel Health for $625 million in cash. The FDA classified a correction of 80,938 Tandem Mobi insulin pumps as its most serious recall type, and two trials published this week address clot prevention after joint replacement and blood pressure drugs on the morning of surgery.

In this episode

• AMA delegates vote that AI cannot hold a medical license or a physician's title, and that vendors should be liable for defective tools
• Patients are more comfortable with AI diagnosis than their doctors think, with a 20-point gap when a clinician can override it
• Oura agrees to buy Counsel Health, whose AI chats escalate to physicians who can diagnose and prescribe, for $625 million in cash
• False alarms on 80,938 Tandem Mobi insulin pumps can halt insulin delivery, in a top-tier recall tied to 230 adverse events
• Aspirin fails to prove noninferior to rivaroxaban or warfarin for clot prevention after hip or knee replacement in an 18,883-patient trial
• Holding ACE inhibitors or ARBs the morning of surgery cuts perioperative hypotension to 31% from 46% in older patients

Much clinical AI is designed for the health systems that pay for it. The doctors who use it should get a vote before it is bought and an off switch for when it slows care.

Read the special topic and its sources: https://physicianintheloop.org/specials/built-for-the-buyer/

The voice on this episode is generated by AI. It reads a special topic from Physician in the Loop as written; every fact in it links to its source.

FDA adds vision-loss warning to every GLP-1 drug, from Ozempic to Zepbound

The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.

Read the post and its sources

Get the free email briefing

The Food and Drug Administration on Nov. 9 ordered a warning about nonarteritic anterior ischemic optic neuropathy, a rare cause of sudden vision loss, added to the labels of every GLP-1 receptor agonist.

The change covers semaglutide, tirzepatide, liraglutide, dulaglutide, the oral drug orforglipron and generic exenatide. In a meta-analysis of 126 randomized trials, the agency counted 6.4 cases per 100,000 person-years with the drugs and 3.8 with comparators; in its Sentinel cohort, the hazard ratio against DPP-4 inhibitors was 1.43.

Google Cloud opened a preview of an AI agent that works across hospitals' records and billing systems, with HCA Healthcare, Highmark Health and Northwell Health as launch partners. An international commission began a four-day review of whether the United States still meets the definition of measles elimination, and the FDA warned that connectors on some ventilator breathing tubes can detach.

In this episode

• FDA requires every GLP-1 drug label to warn of NAION, a rare cause of sudden and possibly permanent vision loss in one eye
• Google opens an AI agent that pulls records from Epic and billing systems and preps prior authorizations, with HCA and Northwell signed on
• International experts weigh whether the U.S. has lost measles elimination after 5,182 cases this year
• Breathing-tube connectors can come loose mid-ventilation, FDA warns, as Intersurgical removes 38 lots of its 22 mm tubes
• Four states sue to stop Medicaid work rules that start Jan. 1 and require 80 hours a month to keep coverage
• Escitalopram and duloxetine top 21 antidepressants for sustained response beyond 12 weeks in a 115-trial analysis
• FDA opens a new device class with a robot that removes bladder tumors in one piece through the urethra
• Five more states join the FTC's suit accusing Hims & Hers of sharing patients' health data with Meta and Snap

Medicare has renamed the diagnostic software it pays hospitals for and parked it in temporary payment groups, an interim step. The next step should pay for software that shows patients do better.

Read the special topic and its sources: https://physicianintheloop.org/specials/medicare-pays-for-software/

The voice on this episode is generated by AI. It reads a special topic from Physician in the Loop as written; every fact in it links to its source.